Wockhardt share price skyrockets 75% in a 12-session rally. Here’s what fuelling the stock price

  • Wockhardt share price has given multibagger returns of more than 118% year-to-date (YTD). In the past one year, Wockhardt share price has surged over 283%.

Ankit Gohel
First Published4 Jul 2024, 10:30 AM IST
Wockhardt share price has skyrocketed by more than 75% over the past 12 days.
Wockhardt share price has skyrocketed by more than 75% over the past 12 days.

Wockhardt shares extended their rally for the twelfth consecutive day, surging nearly 12% on Thursday to reach a fresh 52-week high of 993.35 apiece on the BSE. Over the past 12 days, Wockhardt shares have skyrocketed by more than 75%.

The bullish momentum in Wockhardt shares comes on the back of successful use of its investigational antibiotic Zaynich to treat a cancer patient in the US.

On June 28, Wockhardt announced that a young immune-compromised cancer patient, who has been hospitalized for nearly 9 months at Children's Hospital of Orange County, University of California Irvine School of Medicine was successfully treated with 4 weeks of Zaynich (Zidebactam/Cefepime- WCK 5222) for chronic thigh infection under compassionate use, enabling doctors to resume chemotherapy.

Also Read | Lupin share price jumps 5% after Kotak upgrades stock to an add

It added that the hospital sought the access to Zaynich under a provision termed as ‘Expanded Access IND’ granted by the US FDA.

This case marks the first instance in the US where Zaynich (Zidebactam/Cefepime- WCK 5222) has been employed to combat a complex infection caused by extreme-drug resistant Pseudomonas, Wockhardt said.

Zaynich is currently undergoing a multi-national Phase 3 study which is expected to support its registration/marketing authorization globally.

Also Read | Sensex opens at record high above 80,300, makes shortest 10,000-point run

According to reports, Wockhardt may launch Zaynich at a steep discount in the beginning of next financial year.

Earlier this year, the pharma company had raised 480 crore through a qualified institutional placement (QIP) issue for Zaynich's phase 3 trials. Wockhardt QIP saw investments from a pool of marquee names like funds managed by ace investors Madhusudan Kela and Prashant Jain.

Wockhardt share price has given multibagger returns of more than 118% year-to-date (YTD). In the past one year, Wockhardt shares have surged over 283%.

At 10:25 am, Wockhardt shares were trading 3.90% higher at 922.05 apiece on the BSE.

Read all Stock Market News Updates here

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.MoreLess
First Published:4 Jul 2024, 10:30 AM IST
HomeMarketsStock MarketsWockhardt share price skyrockets 75% in a 12-session rally. Here’s what fuelling the stock price

Most Active Stocks

Tata Steel

168.00
03:59 PM | 10 JUL 2024
-3.8 (-2.21%)

Indian Oil Corporation

171.95
03:59 PM | 10 JUL 2024
0.25 (0.15%)

Bharat Electronics

333.70
03:58 PM | 10 JUL 2024
-0.85 (-0.25%)

Ashok Leyland

225.95
03:52 PM | 10 JUL 2024
-2.4 (-1.05%)
More Active Stocks

Market Snapshot

  • Top Gainers
  • Top Losers
  • 52 Week High

Capri Global Capital

225.65
03:49 PM | 10 JUL 2024
11.15 (5.2%)

Vardhaman Textiles

532.60
03:47 PM | 10 JUL 2024
26 (5.13%)

India Cements

295.50
03:29 PM | 10 JUL 2024
13.85 (4.92%)

NLC India

276.40
03:59 PM | 10 JUL 2024
12.9 (4.9%)
More from Top Gainers

Recommended For You

    More Recommendations

    Gold Prices

    • 24K
    • 22K

    Fuel Price

    • Petrol
    • Diesel
    OPEN IN APP
    HomeMarketsPremiumInstant LoanMint Shorts